NCT03548597View on ClinicalTrials.gov

Evaluation of the Diagnostic of Hepatic Fibrosis With the in Severe Obese Patients Candidates to Bariatric Surgery

CompletedOBSERVATIONAL
Enrollment

132

Participants

Timeline

Start Date

April 4, 2012

Primary Completion Date

January 12, 2015

Study Completion Date

December 6, 2016

Conditions
SteatosisObesityFibrosis, Liver
Interventions
DEVICE

Evaluation of the Diagnostic of Hepatic Fibrosis With the XL Probe of the Fibroscan Versus Biopsies in Severe Obese Patients Candidates to Bariatric Surgery

Evaluation of the Diagnostic of Hepatic Fibrosis With the XL Probe of the Fibroscan Versus Biopsies in Severe Obese Patients Candidates to Bariatric Surgery

Sponsors

Collaborators (1)

Echosens
All Listed Sponsors
collaborator

Echosens

INDUSTRY

lead

European Georges Pompidou Hospital

OTHER

NCT03548597 - Evaluation of the Diagnostic of Hepatic Fibrosis With the in Severe Obese Patients Candidates to Bariatric Surgery | Biotech Hunter | Biotech Hunter